NCM
NAUT icon

Nantahala Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Nantahala Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-289,845
Closed -$522K – 127
2022
Q4 		$522K Sell
289,845
-365,493
-56% -$706K 0.03% 96
2022
Q3 		$1.39M Sell
655,338
-129,460
-16% -$326K 0.09% 84
2022
Q2 		$2.11M Sell
784,798
-108,763
-12% -$405K 0.11% 82
2022
Q1 		$3.88M Sell
893,561
-136,311
-13% -$560K 0.17% 70
2021
Q4 		$5.33M Sell
1,029,872
-14,395
-1% -$77K 0.19% 78
2021
Q3 		$6.41M Sell
1,044,267
-146,543
-12% -$1.17M 0.2% 78
2021
Q2 		$12M Buy
1,190,810
+484,040
+68% +$5.24M 0.34% 61
2021
Q1 		$9.74M Buy
706,770
+6,770
+1% +$93.8K 0.28% 67
2020
Q4 		$7.59M Hold
700,000
– – 0.24% 80
2020
Q3 		$7.57M Buy
+700,000
New +$7.47M 0.23% 72

Other funds holding NAUT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Nantahala Capital Management's NAUT Position: Q1 2023 in Review

Nantahala Capital Management sold out of Nautilus Biotechnolgy (NAUT) in Q1 2023, closing a stake of 289,845 shares — an estimated $522K sold.

Nantahala Capital Management first reported a position in NAUT in Q3 2020 and held it in 10 quarters. The position peaked at $12M in Q2 2021. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2023.

  • Nantahala Capital Management reported no remaining Nautilus Biotechnolgy position as of Q1 2023 after selling out during the quarter.
  • Nantahala Capital Management sold 289,845 Nautilus Biotechnolgy shares in Q1 2023, an estimated $522K.
  • Nantahala Capital Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 10 quarters.
  • Nantahala Capital Management's Nautilus Biotechnolgy position peaked at $12M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2023.

Based on Nantahala Capital Management's 13F filing for Q1 2023, filed 15 May 2023.